AZIROC-500
AZIROC-500 is a pharmaceutical tablet formulation containing Azithromycin 500 mg as its active pharmaceutical ingredient. The product is part of the AZIROC range documented in the Suprimeda product portfolio and is listed under the Antibiotic category. Azithromycin belongs to the macrolide antibacterial class and is formulated for oral administration. Pharmaceutical references identify azithromycin tablets in 500 mg strength as an established oral solid dosage form.
AZIROC-500 provides a defined 500 mg strength of Azithromycin per tablet, making the product suitable for clear pharmaceutical identification, professional product documentation and institutional procurement requirements. The formulation is presented as a conventional tablet dosage form, with the active ingredient and strength clearly specified on the product packaging.
Everything You, Need to Know
AZIROC-500 is presented in a blister-pack format, with the product carton shown in the supplied image specifying a packaging size of 10 × 3 tablets.
AZIROC-500 is an oral tablet formulation containing 500 mg of Azithromycin per tablet. Azithromycin 500 mg is an established oral tablet strength in pharmaceutical references.
AZIROC-500 contains Azithromycin 500 mg as its active pharmaceutical ingredient. The supplied product document lists the AZIROC range with Azithromycin 250 mg/500 mg Tablets.